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Quorum sensing, a process of bacterial cell-cell
communication, relies on production, detection, and
response to autoinducer signaling molecules. LuxN,
a nine-transmembrane domain protein from Vibrio
harveyi, is the founding example ofmembrane-bound
receptors for acyl-homoserine lactone (AHL) autoin-
ducers.We usedmutagenesis and suppressor analy-
ses to identify the AHL-binding domain of LuxN and
discovered LuxNmutants that confer both decreased
and increased AHL sensitivity. Our analysis of dose-
response curves of multiple LuxNmutants pins these
inverse phenotypes onquantifiable opposing shifts in
the free-energy bias of LuxN for occupying its kinase
and phosphatase states. To understand receptor ac-
tivation and to characterize the pathway signaling pa-
rameters,we exploited a strong LuxNantagonist, one
of fifteen small-molecule antagonists we identified.
We find that quorum-sensing-mediated communica-
tion can be manipulated positively and negatively to
control bacterial behavior and,morebroadly, that sig-
naling parameters can be deduced from in vivo data.
INTRODUCTION
Quorumsensing is aprocess of bacterial cell-cell communication
that involves production and detection of secreted signaling
molecules called autoinducers (Waters and Bassler, 2005). Quo-
rum sensing allows bacteria to collectively regulate gene expres-
sion and thereby function as multicellular organisms. The biolu-
minescent Gram-negative quorum-sensing bacterium Vibrio
harveyi integrates information from three different diffusible auto-
inducers that together enable intra- and interspecies communi-
cation (Henke and Bassler, 2004b). The three V. harveyi autoin-
ducers are AI-1 (3-hydroxybutanoyl homoserine lactone), AI-2
[(2S,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran-borate],
and CAI-1 [(S)-3-hydroxytridecan-4-one] (Bassler et al., 1993;
Cao and Meighen, 1989; Chen et al., 2002; Higgins et al., 2007;
Surette et al., 1999). These signals are detected by the sensor-
kinase proteins, LuxN, LuxQ, and CqsS, respectively (Figure 1A)(Henke and Bassler, 2004b). At low cell density, (i.e., in the
absence of autoinducers), these sensor kinases autophosphory-
late and transfer phosphate to the shared phosphotransfer pro-
tein, LuxU (Freeman and Bassler, 1999a, 1999b). LuxU transfers
the phosphoryl group to the DNA-binding response regulator,
LuxO, which activates transcription of genes encoding five
redundant small regulatory RNAs called the quorum regulatory
RNAs (Qrrs) (Figure 1A) (Lenz et al., 2004; Tu and Bassler,
2007). The Qrrs destabilize the mRNA transcript encoding the
master quorum-sensing regulator, LuxR (Martin et al., 1989;
Showalter et al., 1990; Svenningsen et al., 2008). Therefore,
under low-cell-density conditions, the bacteria do not display
quorum-sensing behaviors. In contrast, at high cell density, the
three autoinducers accumulate and bind to their cognate recep-
tors. These binding events switch the receptors to phosphatases,
resulting indephosphorylation of LuxOand terminationofQrr pro-
duction. The luxR transcript is stabilized, leading to LuxR protein
production (Figure 1A) (Tu and Bassler, 2007). LuxR controls the
genes in the quorum-sensing regulon, including those required
for bioluminescence, siderophore production, type III secretion,
and metalloprotease production (Fuqua et al., 1996; Hammer
and Bassler, 2003; Henke and Bassler, 2004a; McFall-Ngai and
Ruby, 2000; Miller and Bassler, 2001; Waters and Bassler, 2005).
AI-1 is an acyl-homoserine lactone (AHL), and it is the strongest
of the three V. harveyi signals and, thus, the major input control-
ling quorum-sensing-regulated behaviors (Henke and Bassler,
2004b). Typically, AHLautoinducers are detectedby cytoplasmic
LuxR-type transcriptional activators (Note: These LuxR-type pro-
teins are unrelated to V. harveyi LuxR, Figure 1A) (Fuqua et al.,
1994, 1996, 2001;Engebrecht andSilverman, 1984, 1987).V. har-
veyi is unusual because all three of its autoinducers, including AI-
1, are detected by membrane-bound sensor-kinase proteins (in
the case of AI-2, however, an additional periplasmic binding pro-
tein, LuxP, is required in conjunction with the membrane-bound
two-component protein, LuxQ). AI-1 is also the defining member
of a growing family of recognized AHLs that interact with mem-
brane-bound sensor kinases like LuxN, rather than with cytosolic
LuxR-type proteins (Freeman et al., 2000; Jung et al., 2007; Tim-
men et al., 2006). There are currently 11 LuxN homologs in the
NCBI database, but nothing is known about how AHLs interact
with this important class of receptors (Figure S2 available online).
Membrane-topology analysis predicts that LuxN is bound
to the bacterial inner membrane by nine transmembraneCell 134, 461–473, August 8, 2008 ª2008 Elsevier Inc. 461
Figure 1. The V. harveyi Quorum-Sensing Circuit and
the LuxN Transmembrane Domain
(A) The autoinducer receptor systems are CAI-1/CqsS, AI-1/
LuxN, and AI-2/LuxPQ. CAI-1 is (S)-3-hydroxytridecan-4-one
(squares), AI-1 is 3-hydroxybutanoyl homoserine lactone
(ovals), and AI-2 is (2S,4S)-2-methyl-2,3,3,4-tetrahydroxyte-
trahydrofuran-borate (triangles), and they are synthesized by
CqsA, LuxM, and LuxS, respectively. At low cell densities, in
the absence of appreciable autoinducer, CqsS, LuxN, and
LuxQ act as kinases funneling phosphate via LuxU to LuxO
(arrows). Phospho-LuxO activates expression of the qrr
genes; the Qrr sRNAs (comb shapes) are transcribed, and
they bind to and facilitate the degradation of themRNA encod-
ing LuxR. Without LuxR, there is no quorum sensing and thus
no light production. At high cell density, in the presence of
autoinducers, the receptors act as phosphatases, draining
phosphate from LuxO via LuxU. Transcription of the qrr genes
is terminated, the LuxR mRNA is stabilized, and LuxR protein
is produced. By activating and repressing a variety of genes,
LuxR facilitates the transition of the cells into quorum-sensing
mode. One operon activated by LuxR at high cell density
encodes luciferase, so in the presence of autoinducers,
V. harveyi produces light.
(B) The cartoon depicts the putative topology of the N-termi-
nal region of LuxN. Amino acids in red, when mutated, confer
a dark phenotype. Amino acids in blue denote sites where
mutations enhance sensitivity of LuxN to AI-1. The amino
acid in green represents the LuxN* suppressor mutation
that prevents C450-0730 antagonism.(TM)-spanning helices (Figure 1B) (Jung et al., 2007). The N ter-
minus of LuxN is on the periplasmic side of the bacterial inner
membrane, whereas the histidine-kinase portion of LuxN resides
in the cytosol, as judged by reporter-protein fusion analyses
(Jung et al., 2007). Therefore, LuxN contains four periplasmic
loops and four cytosolic loops connecting the nine TM segments
(Figure 1B). By analogy to homologous membrane-bound sen-
sor kinases, LuxN is believed to assemble into homodimers
(Park et al., 1998). To locate the AI-1 binding domain of LuxN,
we performed a genetic screen to identify luxN mutants encod-
ing proteins incapable of properly responding to AI-1. We found
that the LuxN AI-1 binding domain is composed of TM helices 4,
5, 6, and 7, as well as the intervening periplasmic loops 2 and 3.
We also used a high-throughput chemical screen to identify a set
of small molecules that specifically antagonize the LuxN/AI-1 in-
teraction. All of these LuxN antagonist molecules have IC50
values in the low micromolar range, and, on the basis of compe-
tition assays and genetic evidence, the most potent LuxN antag-
onist competes for the AI-1 binding site. These antagonists
provided a molecular tool to further probe the AI-1 binding
pocket and characterize the signaling properties of V. harveyi
LuxN. Quantitative analysis of the sensing and binding proper-
ties of our LuxN mutants suggests a two-state, kinase-versus-
phosphatase model for receptor function. Indeed, when signal-
ing output (bioluminescence) was plotted as a function of the
free-energy difference between kinase and phosphatase states,462 Cell 134, 461–473, August 8, 2008 ª2008 Elsevier Inc.our data collapsed to a single curve, allowing us to extract signal-
ing parameters for both wild-type and mutant LuxN proteins.
Only through this quantitative analysis was it revealed that, un-
like the paradigmatic two-state chemotaxis receptors that spend
roughly equal time in the active and inactive states for maximum
sensitivity to ligand (Sourjik, 2004; Sourjik and Berg, 2004), the
quorum-sensing receptor LuxN spends 96% of its time in the
active-kinase state and requires establishment of a threshold
concentration of autoinducer to inactivate it. Remarkably,
although the chemotaxis and LuxN receptors are homologous,
they solve fundamentally different biological problems by oper-
ating in different regimes. Chemotaxis, a system tuned for sensi-
tivity, allows instantaneous alterations in behavior in response to
small fluctuations in signal concentration. In contrast, quorum
sensing, a system built to ignore small perturbations, initiates
a slow, all-or-nothing commitment program only upon reaching
a signal threshold.
RESULTS
Identification of LuxN Mutants with Defective
Responses to AI-1
The aim of this study was to determine how LuxN and AI-1
interact in order to understand how transmembrane receptors
couple AHL signaling to changes in gene expression. However,
as is the case for most histidine sensor kinases, the complex
transmembrane topology of LuxN makes direct structural analy-
sis extremely difficult. Therefore, to pinpoint the AI-1 binding site
in the periplasmic domain of LuxN, we performed directedmuta-
genesis of the 1 kb region of luxN encoding the membrane-bind-
ing domain using error-prone PCR. The library of luxN mutants
generated by this approach was cloned into a version of the
luxN gene lacking this region to regenerate full-length luxN.
Themutant library was introduced into the double sensor mutant
JMH625 (luxN luxQ), which has a bright phenotype because
there is no flow of phosphate to LuxO (Figure 1A). We note that
the CAI-1-CqsS system is intact in the strain used for this screen.
Because saturating levels of CAI-1 are always present in our
experiments, CqsS exists as a phosphatase and thus does not
contribute in funneling phosphate to LuxO. We reasoned that
when a wild-type copy of luxN is introduced into this strain in
the presence of AI-1, it would remain bright because binding of
AI-1 to LuxN induces phosphatase activity. However, if a mutant
luxN allele encoding a LuxN protein that is incapable of binding
or responding to AI-1 is introduced, it will confer a dark pheno-
type because of high levels of LuxN autophosphorylation and
phosphotransfer to LuxO (Figure 1A).
Approximately 30,000 luxN mutants were screened for those
alleles causing a reduction in bioluminescence. Ten alleles
were confirmed to produce dark phenotypes. These luxN genes
were sequenced to identify the mutations (Table S1, Figure 1B).
Several candidates contained multiple mutations, and these
mutations were uncoupled by site-directed mutagenesis to pro-
duce genes encoding LuxN proteins with single amino acid sub-
stitutions (Table S1). Interestingly, in the case of LRS6, two of the
uncoupled mutations independently caused dark phenotypes
(Table S1). Further analyses were carried out on LuxN mutants
containing only single amino acid changes.
The mutations conferring dark phenotypes cluster to the peri-
plasmic region of TMs 4, 5, 6, and 7 and periplasmic loops 2 and
3 (Figure 1B in red) suggesting that the AI-1 binding site resides
there. To explore this hypothesis further, we compared the 11
available LuxN homologs and replaced every 100% conserved
amino acid, as well as the other most highly conserved amino
acids within this region with alanine, and screened them as
above. This analysis produced an additional 20 mutants defec-
tive in response to AI-1. (Table 1, Figure 1B).
The LRS5 mutation, which confers a dark phenotype, is a
single-base-pair deletion at position 634 causing a premature
stop codon at amino acid residue 213 (Table S1). This mutation
is perplexing because the kinase domain of LuxN should not be
synthesized, making it unclear how this mutation could confer
a dark phenotype. So that this could be investigated, a FLAG-
epitope tag was fused to the C terminus of this mutant LuxN
and the protein was probed bywestern blot analysis. A truncated
version of LuxN lacking approximately the first 220 amino acids
was synthesized (data not shown). We therefore suspect that
an alternative ribosome binding site exists downstream of
the LRS5 deletion, enabling translation of a truncated form of
LuxN. Because this truncation eliminates almost the entire
proposed AI-1 binding domain from LuxN, only the cytoplasmic
kinase domain is produced, which, because it is unable to bind
to AI-1, constitutively acts as a kinase, causing a dark
phenotype.LuxN Mutant Phenotypes
To characterize the signaling capabilities of the single-amino-
acid-substituted LuxN mutants, we carried out a series of
quantitative phenotypic analyses. First, we measured biolumi-
nescence in stationary-phase cultures of strains carrying either
wild-type luxN or each luxN allele conferring a dark phenotype.
The bioluminescence produced by the strain with wild-type
luxN was set at 100% (Figure S1A). As negative controls, two
luxN mutants harboring wild-type phenotypes (LuxN L138A
and LuxN E154Q) that were randomly isolated from the screen
were also included in the analysis, and they produced the wild-
type level of bioluminescence (Figure S1A). In contrast, the
LuxN mutants F151A, I153F, F155I, L166R, T214I, F220A,
P226T, and S232N exhibited at least an 80% reduction in biolu-
minescence relative to the wild-type (Figure S1A). To confirm
that the dark phenotypes did not stem from increased LuxN pro-
tein levels, we incorporated FLAG-epitope tags at the C terminus
of a representative subset of the LuxN mutants shown in Figure
S1A, as well as wild-type LuxN. Western blot showed that there
were no differences in protein production (data not shown).
We reasoned that the LuxN mutants conferring dark pheno-
types must be acting as kinases at high cell density, resulting
in continued flow of phosphate through the quorum-sensing cir-
cuit. This in turn, should manifest itself in elevated qrr expression
at high cell density (Figure 1A). To test this idea, we performed
quantitative real-time PCR and measured Qrr4 transcript levels
in each of the luxNmutant strains described above. As controls,
we measured Qrr4 transcript levels in the wild-type and the
bright control strains, LuxN L138A and LuxN E154Q, and found
that indeed, in these three strains, Qrr4 levels are low, consistent
with these LuxN proteins acting as phosphatases at high cell
density (Figure S1B). However, the luxN mutants exhibiting
dark phenotypes (Figure S1A) all have significantly increased
Qrr4 transcript levels (10- to 30-fold higher than that of the
wild-type) (Figure S1B). This result confirms that the decrease
in bioluminescence we observe in the dark LuxN mutants is
the direct result of an alteration in signaling through the LuxN
quorum-sensing pathway.
AI-1 Dose-Response Curves
We considered two possible mechanisms underlying the dark
LuxN phenotypes. First, a particular mutation could abolish AI-
1 binding. If so, this type of mutation would cause LuxN to act
as a kinase at high cell density in the presence of AI-1. Alterna-
tively, a mutation could allow AI-1 binding but disrupt the ability
of LuxN to transduce the signal to the cytoplasm. We first deter-
minedwhich LuxNmutant proteins could bind AI-1 bymeasuring
the AI-1 dose response of each LuxN missense mutant. For this,
V. harveyi strain HLS253 DluxMN, DluxPQ, DluxS was used.
V. harveyi HLS253 is constitutively bright because the luxN and
luxPQ genes, encoding the quorum-sensing receptors, have
been deleted. Also, V. harveyi HLS253 does not produce AI-1
or AI-2, because of the luxM and luxS deletions, respectively.
Introduction of a wild-type copy of luxN into V. harveyi HLS253
confers a dark phenotype because, in the absence of AI-1,
LuxN acts as a constitutive kinase. However, addition of exoge-
nous AI-1 to HLS253 harboring a wild-type copy of luxN induces
bioluminescence. Introduction of a luxNmutant encoding a LuxNCell 134, 461–473, August 8, 2008 ª2008 Elsevier Inc. 463
Table 1. LuxN Mutant Phenotypes
Allele
Lux
Phenotype AI-1 EC50 (M)
Fold
Change
in EC50
a Location
Wild-type WT 2.3 3 108
H46Y WT NM TM2
S54P WT NM TM2
A77D WT NM PL1
H155Q WT NM CL1
N133Ab Dark 8.2 3 108 3.6 TM4
L138A WT 3.0 3 108 1.3 TM4
T139A WT 1.4 3 108 0.6 TM4
T139I Dark 7.4 3 108 3.2 TM4
V140A WT NM PL2
V143A Dark 9.9 3 108 4.3 PL2
I145A WT NM PL2
P148A WT NM PL2
S149A WT 6.1 3 108 2.7 PL2
F151A Dark 6.9 3 105 3000 PL2
I153A Dark 1.2 3 106 52.2 PL2
I153F Dark 1.3 3 107 5.7 PL2
I153L WT 6.6 3 108 2.9 PL2
E154Q WT 5.5 3 108 2.4 PL2
E154A WT NM PL2
F155A Dark 5.8 3 107 25.2 PL2
F155I Dark 8.1 3 104 35217 PL2
F155L Dark 4.1 3 106 178.3 PL2
G156A WT NM PL2
P157A WT NM PL2
F162A Dark 9.3 3 105 4043 TM5
F163A Dark 8.7 3 106 378.3 TM5
L166A Dark NA TM5
L166R Dark 2.3 3 107 10.0 TM5
V170A WT NM TM5
T173A WT NM TM5
N176A WT NM TM5
S184N Sensitive 1.1 3 108 0.5 CL2
K186A WT NM CL2
L187A WT NM CL2
A190T WT NM CL2
K191A WT NM CL2
Y194A WT NM TM6
G198A WT NM TM6
I199A WT NM TM6
F202A Dark NA TM6
F202Y Dark 7.1 3 107 30.9 TM6
S205A WT 3.2 3 108 1.4 TM6
S205P Dark NA TM6
T206A Dark 3.1 3 107 13.5 TM6
I209F WT 3.9 3 108 1.7 TM6
G212A WT 3.6 3 108 1.6 TM6464 Cell 134, 461–473, August 8, 2008 ª2008 Elsevier Inc.protein incapable of binding AI-1 or incapable of signaling the
AI-1 binding event to the cytoplasm will confer a dark phenotype
to HLS253. And, such defects will cause the LuxN proteins to
remain as kinases even in the presence of AI-1. In contrast, if
a particular LuxN mutant is introduced that is capable of binding
AI-1, even with lower affinity than wild-type LuxN, these LuxN
proteins will switch to phosphatase activity after the addition of
sufficient AI-1, and bioluminescence will be induced.
To determine AI-1 EC50 values, we assayed wild-type LuxN
and each LuxN mutant for response to AI-1 at concentrations
ranging from 24 pM to 500 mM. A subset of the dose-response
curves is shown in Figure 2A, and the remainder of the EC50
data is provided in Table 1. The EC50 for wild-type LuxN binding
to AI-1 is 23 nM. The control mutants, LuxN L138A and LuxN
E154Q, as expected, have EC50 values of 30 nM and 55 nM, re-
spectively, similar to wild-type LuxN (Table 1). Many of the LuxN
Table 1. Continued
Allele
Lux
Phenotype AI-1 EC50 (M)
Fold
Change
in EC50
a Location
T214A Dark 4.5 3 107 19.6 TM6
T214I Dark 7.0 3 105 1043 TM6
D219A Dark 1.3 3 107 5.7 PL3
F220A Dark 1.9 3 104 8261 PL3
F220I Dark 7.1 3 104 30870 PL3
S221A Dark 1.9 3 107 8.3 PL3
W224A Dark 1.9 3 107 8.3 TM7
L225A WT 5.5 3 108 2.4 TM7
P226A Dark 2.3 3 104 10000 TM7
P226T Dark NA TM7
P227A Dark 4.0 3 106 173.9 TM7
P227L Dark 3.9 3 103 169565 TM7
L229A WT NM TM7
S230A WT NM TM7
S232A Dark 4.0 3 107 17.4 TM7
S232N WT 4.1 3 108 1.8 TM7
E233A Dark NA TM7
M234I WT NM TM7
M234A WT NM TM7
G238A WT NM TM7
Y239A WT NM TM7
R245L Sensitive 4.8 3 109 0.21 CL4
V249I WT NM CL4
G271D Sensitive 3.7 3 109 0.16 TM8
F163A/R245L Dark 3.7 3 106 160.9
F163A/R245L/
S184N
Dark 1.4 3 107 6
F163A/R245L/
S184N/G271D
Sensitive NA
TM, transmembrane domain; CL, cytoplasmic loop; PL, periplasmic loop;
NM, not measured; NA, not applicable.
a Fold change in EC50 value with respect to wild-type EC50 value.
b Italics indicate 100% conserved amino acids (see Figure S2).
mutants have drastically increased EC50 values (Table 1). For
example, LuxN I153F, F155A, F162A, T206A, and S232A have
EC50 values of 130 nM, 580 nM, 93 mM, 310 nM, and 400 nM,
respectively (Figure 2A). In five cases, LuxN L166R, F202A,
S205P, P226T, and E233A, the mutants conferred a dark pheno-
type to V. harveyi even at 500 mM AI-1 (Figure 2B), and therefore
we were unable to assign them EC50 values. Nonetheless, we
successfully determined the AI-1 EC50 values for 25 of the 30
LuxN mutants that conferred a dark phenotype. We conclude
that LuxNmutant proteins that producemeasurable EC50 values,
albeit higher than the wild-type, can bind AI-1 at least with some
capacity.
Identification of LuxN Antagonists
To probe the LuxN/AI-1 interaction further, we identified small
molecules that interfere with V. harveyi quorum sensing by dis-
rupting the binding of AI-1 to LuxN. To do this, we carried out
a high-throughput chemical screen (Broad Institute), in which
we identified small molecules that specifically antagonize LuxN
signaling in V. harveyi. The V. harveyi strain, JMH624 DluxPQ,
DluxM, which lacks the AI-2 receptor, LuxPQ, as well as the
AI-1 synthase, LuxM, was used for the antagonist screen. V. har-
veyi JMH624 is dark because there is no AI-2 receptor, and the
Figure 2. LuxN AI-1 Dose-Response Curves
(A) Light production at various AI-1 concentrations is shown for wild-type LuxN
and for representative LuxN mutants that have increased AI-1 EC-50 values.
The data were fit with a variable-slope sigmoidal dose-response curve to de-
termine the EC50 values.
(B) Light production at various AI-1 concentrations is shown for wild-type LuxN
and for representative LuxN mutations that cause constitutive dark pheno-
types at all AI-1 concentrations. EC50 values were not determined for these
mutants.
Error bars, although small, are included in the figure and represent the stan-
dard error of the mean for three or more independent trials.lack of AI-1 causes LuxN to act as a kinase (Figure 1A). However,
after exogenous addition of 20 nM AI-1, bioluminescence is in-
duced because LuxN switches to phosphatase mode. Potential
antagonist molecules were tested for the ability to reduce biolu-
minescence of V. harveyi JMH624 in the presence of 20 nM AI-1.
To eliminate molecules causing general toxicity and those that
interfere with luciferase or other downstream components of
the quorum-sensing bioluminescence pathway, we carried out
a second screen using a V. harveyi DluxN, DluxS control strain,
JHM610. V. harveyi JMH610 lacks the AI-1 receptor LuxN and
the AI-2 synthase, LuxS. In this case, because of the lack of
AI-2, LuxQ acts as a kinase, and V. harveyi JMH610 is dark.
However, after exogenous addition of AI-2, bioluminescence is
induced because LuxQ switches to phosphatase mode (Fig-
ure 1A). Any molecule that reduced bioluminescence in both
JMH610 in the presence AI-2 and JMH624 in the presence of
AI-1 was eliminated from further analysis. Approximately
35,000 low-molecular-weight compounds were screened for
specific inhibition of bioluminescence through the LuxN quo-
rum-sensing pathway; 45 molecules were selected for further
analysis, and a representative subset of these molecules with
varying levels of antagonistic activity is shown in Figure 3A. For
example, molecule C450-0730 has an IC50 value of 2.7 mM,
whereas a weaker antagonist, 3578-0898, has an IC50 of
62.3 mM. Interestingly, the molecular cores of two of the stron-
gest LuxN antagonists, C450-0730 and C646-0078, are very
similar (Figure 3A).
We wondered whether the potent LuxN antagonist, C450-
0730, was competing for the LuxN AI-1 binding site. To examine
this, we determined AI-1 EC50 values in the presence of 0 mM,
1mM,and10mMC450-0730.Our rational is that ifC450-0730com-
petes with AI-1 for binding, the AI-1 EC50 value should increase
with increasing concentrations of C450-0730. Indeed, this is
the case, as the AI-1 EC50 values are 23 nM, 76 nM, and 376
nMat0mM,1mM,and10mMC450-0730, respectively (Figure3B).
Indeed, the AI-1 dose-response curves at these threeC450-0730
concentrations can be collapsed onto a single curve, consistent
with competitive inhibition (Figure 3C and the Experimental
Procedures). The principal underlying the data collapse is that
there is a fixed (albeit initially unknown) quantitative relation be-
tween measured bioluminescence and the free-energy differ-
ence between the active and inactive configurations of LuxN
(Keymer et al., 2006). Therefore, all of our dose-response curves
should reproduce this same relation, i.e., the curves should
‘‘collapse’’ when bioluminescence is plotted versus free-energy
difference. However, to plot the data this way, we need to know
how to relate ligand concentrations to free-energy differences,
which means that we need to know the ligand dissociation
constants KD for both the active and inactive configurations of
LuxN. In practice, we iteratively improve our estimates for KD
values by attempting to collapse the dose-response curves and
infer the true values from the best data collapse. This is a reliable
procedure in our case because the dose-response curves con-
tain more data than the number of unknown KD values. A major
benefit of collapsing the data in this way is that it allows us to
deduce the state-dependent KD values for LuxN from the
in vivo data: In the phosphatase (off) state, KAI-1off z1 nM, and
in the kinase (on) state, KC450-0730on z500 nM.Cell 134, 461–473, August 8, 2008 ª2008 Elsevier Inc. 465
We had reasoned that the dark phenotypes of our LuxN
mutants could stem from (1) a defect in the ability to bind AI-1,
(2) a bias favoring the kinase state, (3) a defect in signaling, or
(4) some combination of the above. The method of data collapse
provides us with a powerful tool to distinguish among these pos-
sibilities. For example, we consider the case of the mutant LuxN
F163A (Figure 3B), which has an AI-1 EC50 value 378-fold higher
than that of wild-type LuxN and for which we obtained dose-
response curves in the presence of 0 mM, 1 mM, and 10 mM of
the antagonist C450-0730. First, we were able to collapse
the three antagonist dose-response curves using the identical
K
AI-1=C450-0730
on=off as we used to collapse the wild-type LuxN data,
indicating that LuxN F163A is not defective in its ability to bind
AI-1 (eliminating possibility 1). Second, the LuxN F163A data
could all be collapsed onto the wild-type LuxN antagonist curves
simply by adjusting the free-energy bias between the kinase (on)
and phosphatase (off) states (Figure 3C). This analysis allows us
to conclude that LuxN F163A has an increased AI-1 EC50 value
exclusively because it has an altered free-energy bias that favors
the kinase (on) state, establishing that possibility 2 accounts for
the dark phenotype of this mutant. Similar analysis applied to our
other dark mutants reveals examples of the different possibilities
and allows us to deduce and quantify the origins of the dark
phenotypes (see the Discussion).
Figure 3. Molecules that Antagonize LuxN-
AI-1 Binding or Signaling
(A) Structures and designations of five molecules
that inhibit LuxN signaling in response to AI-1.
The IC50 value for each antagonist molecule is
given below its structure.
(B) Light production from wild-type LuxN and
LuxN F163A was measured at the specified AI-1
concentrations in the presence of 0 mM, 1 mM,
and 10 mMC450-0730. Data were fit as described
in Figure 2.
(C) The light production values in (B) were col-
lapsed as a function of f-D3WT as described in
the Experimental Procedures. f is the ligand-
dependent free-energy difference between the
kinase active (on) and kinase inactive (off) states
of LuxN, and D3WT is the wild-type value of f in
the absence of ligand. The binding parameters
used are as follows: KAI-1off = 1nM; K
AI-1
on = 1mM;
KC450-0730off = 1mM; and K
C450-0730
on = 500nM. The
collapse was obtained by using D3D3WT = 3.2
for the LuxN F163A mutant.
Error bars, although small, are included in the fig-
ure and represent the standard error of the mean
for three or more independent trials.
Antagonist Suppressor Analysis
To better understand the mechanism of
C450-0730 interaction with LuxN, we
performed a suppressor screen to iden-
tify LuxN mutants no longer antagonized
by C450-0730. Through the use of error-
prone PCR, 2000 mutants in the luxN
N-terminal region were generated and
conjugated into the V. harveyi DluxMN
DluxPQ DluxS strain, HLS253, and arrayed in 96-well microtiter
plates. As mentioned, V. harveyi HLS253 is constitutively bright
because of the absence of the quorum-sensing receptors,
LuxN and LuxPQ, and both autoinducer synthases, LuxM and
LuxS. To verify our strategy, we also conjugated a wild-type
luxN control plasmid into V. harveyi HLS253, which conferred
a dark phenotype because wild-type LuxN is a kinase in the
absence of AI-1. Bioluminescence is restored to HLS253 con-
taining wild-type luxN by the exogenous addition of 100 nM
AI-1. We found that 800 nM C450-0730 was required to inhibit
bioluminescence of HLS253 carrying wild-type luxN in the pres-
ence of 100 nMAI-1. The luxNmutant library was screened in the
presence of 100 nM AI-1 and 800 nM C450-0730 for luxN alleles
that enabled bioluminescence in V. harveyiHLS253. To eliminate
luxN null mutants, we also screened the luxN mutant library in
V. harveyi HLS253 in the absence of both AI-1 and C450-0730.
The luxN alleles that conferred a bright phenotype in the absence
of AI-1 were not examined further. Five LuxN mutant strains,
LRS112, LRS311, LRS129, LRS147, and LRS1511 (Table S1),
displayed dark phenotypes in the absence of AI-1 and C450-
0730 but were bright in the simultaneous presence of AI-1 and
C450-0730, suggesting that these LuxN proteins were no longer
antagonized by C450-0730. The luxN mutations were se-
quenced to identify the alleles (Table S1). Interestingly, LuxN466 Cell 134, 461–473, August 8, 2008 ª2008 Elsevier Inc.
G271D was identified twice. From here forward, this class of
suppressor mutants is referred to as LuxN*.
Characterization of the LuxN* Mutants
We speculated that the LuxN* mutants could have increased
AI-1 sensitivity or decreased C450-0730 binding ability. To dis-
tinguish between these two possibilities, we determined the
LuxN* AI-1 EC50 values (Figure 4A). As a reference, the dark mu-
tant LuxN F163A is also included in Figure 4A. The EC50 value of
wild-type LuxN is 23 nM, whereas LuxN* S184N is 11 nM, LuxN*
I209F is 39 nM, LuxN* R245L is 4.8 nM, and LuxN* G271D is
3.7 nM (Table 1). Interestingly, three of the four LuxN* mutants,
LuxN S184N, R245L, and G271D, show increased sensitivity to
AI-1, suggesting that these alleles circumvent C450-0730 antag-
onism through increased AI-1 binding or signaling or via a bias to
the phosphatase state of LuxN (see the Discussion). However,
LuxN* I209F responded more like the wild-type to AI-1, as indi-
cated by an AI-1 EC50 value of 39 nM (Table 1).
In the reciprocal experiment, we determined the ability of
C450-0730 to antagonize the LuxN* mutants. C450-0730 IC50
values were measured by titrating C450-0730 from 0.64 nM to
50 mM while keeping the AI-1 concentration constant at 10 nM.
The C450-0730 concentration required to inhibit LuxN* G271D,
R245L, and S184N was similar to that required to inhibit wild-
type LuxN, indicating that the observed ‘‘resistance’’ to C450-
0730 was indeed due to increased sensitivity to AI-1 (data not
shown). However, a 5-fold higher concentration of C450-0730
was required to antagonize LuxN* I209F. Therefore, the LuxN*
I209F mutation appears to affect C450-0730 binding. Because
I209 is located within our proposed AI-1 binding site (Figure 1B
in green), and because it also affects C450-0730 antagonistic
activity, we propose that C450-0730 could compete for the
AI-1 binding site of LuxN. This hypothesis is strongly supported
by the good data collapse in Figure 3C, which is based on
competitive inhibition by C450-0730.
Sensitive LuxN* Mutations Are Epistatic
to the LuxN Dark Mutations
For chemotaxis receptors in E. coli, adaptive methylation of spe-
cific cytoplasmic residues is known to additively bias receptors
toward a kinase-active state (Endres et al., 2007). By analogy,
we wondered whether some of our single-residue mutations
might bias LuxN toward kinase or phosphatase states in an ad-
ditive manner. So that it could be determined whether the LuxN
G271D, R245L, and S184Nmutants, which have lower thanwild-
type AI-1 EC50 values, are biased toward the phosphatase state,
these mutations were engineered into the LuxN F163Amutant to
test whether they could shift the high EC50 of LuxN F163A back
toward a low EC50. As a reminder, the F163A LuxN mutation has
an increased AI-1 EC50 value of 8.7 mMas compared to 23 nM for
wild-type LuxN; therefore, it requires approximately 378 times
more AI-1 to switch LuxN F163A into the phosphatase mode
than the amount of AI-1 required to switch wild-type LuxN. A
double mutant (LuxN F163A/R245L), a triple mutant (LuxN
F163A/R245L/S184N), and a quadruple mutant (LuxN F163A/
R245L/S184N/G271D) of LuxN were tested for their ability to
respond to AI-1 (Figure 4B). The incorporation of each LuxN*
mutation into the context of the F163Amutation successively de-creased the AI-1 EC50 value approximately 10-fold, whereas the
quadruple mutant had a constitutively bright phenotype (Table
1). This analysis suggests that the LuxN* mutations are additive
in their ability to bias LuxN toward the phosphatase mode.
DISCUSSION
LuxN is the founding member of a growing family of recognized
membrane-bound receptors that detect and respond to AHL
quorum-sensing autoinducers. AHLs are used by a broad spec-
trum of Gram-negative bacteria to control quorum-sensing
behaviors, including virulence (Fuqua et al., 1996; Waters and
Bassler, 2005). Typically, cytoplasmic LuxR-type proteins detect
and respond to the accumulation of an AHL signal (Fuqua et al.,
1994, 1996; Engebrecht and Silverman, 1984, 1987). Little is
known about how membrane-bound kinase proteins, like LuxN,
detect AHLs. Our mutagenesis strategy identified the AI-1 bind-
ing domain of LuxN from V. harveyi as TM helices 4, 5, 6, and 7,
as well as the intervening periplasmic loops 2 and 3 (Figure 1B).
All of the identified amino acidmutations that affect AI-1 signaling
cluster in TM helices near the periplasmic face or are located
within periplasmic loops, indicating that LuxN most likely binds
AI-1 on the periplasmic side of the membrane (Figure 1B). This
observation indicates that AI-1 is released from V. harveyi, accu-
mulates in the extracellular space, and subsequently triggers the
LuxN quorum-sensing cascade. This mechanism is distinct from
the previously characterized LuxR-type AHL-signaling mecha-
nism. Typically, LuxR-type AHL receptors require significant
Figure 4. AI-1 Dose-response Curves of the LuxN* Suppressor
Mutants
(A) Light production of the wild-type LuxN, the LuxN* mutants, and LuxN
F163A at various AI-1 concentrations. The data were fit with a variable-slope
sigmoidal dose-response curve to determine the EC50 value for each LuxN*
mutant.
(B) Light production of the dark LuxN F163Amutant harboring combinations of
LuxN* mutations. Data were fit and AI-1 EC50 value was determined as above.
An EC50 value could not be determined for the quadruple mutant because it is
constitutively bright at all AI-1 concentrations.
Error bars, although small, are included in the figure and represent the
standard error of the mean for three or more independent trials.Cell 134, 461–473, August 8, 2008 ª2008 Elsevier Inc. 467
intracellular AHL concentrations for folding (Zhu and Winans,
2001). Thus, at low cell densities, the LuxR proteins do not fold
properly and are degraded, so quorum sensing does not occur
(Zhu and Winans, 1999). Degradation of the LuxR-type proteins
in the absence of the AHL signal is presumed to be amechanism
preventing premature activation of quorum sensing in canonical
LuxR-AHL systems (Zhu and Winans, 2001). Apparently, V. har-
veyi has evolved a distinct mechanism to circumvent short
circuiting its quorum-sensing pathway, namely by compartmen-
talizing the cytosolic production of AI-1 in a location inaccessible
to the periplasmic sensing domain of LuxN. This spatial uncou-
pling of AI-1 production from AI-1 binding allows V. harveyi to ex-
clusively monitor extracellular levels of AI-1. It must be noted that
V. harveyi has three quorum-sensing circuits, all of which have
similar architectures (Henke and Bassler, 2004b). Thus, all three
systems have signal production spatially uncoupled from signal
detection (Figure 1A).
The large number of mutations identified in this work that
affect AI-1 binding suggest that LuxN makes multiple contacts
with AI-1. Further supporting our hypothesis that TM4, TM5,
TM6, and TM7 and periplasmic loops 2 and 3 encode the AI-1
binding domain of wild-type LuxN, a LuxN homolog was recently
discovered that lacks the first 80 amino acids, which encode
TM1, TM2, and periplasmic loop 1, indicating that this region
of LuxN is dispensable for AI-1 binding and signaling (Figure S2
and NCBI database). This truncated LuxN homolog retains all of
the critical regions identified in our proposed AI-1 binding do-
main, indicating that this LuxN variant can still respond to an
autoinducer molecule (Figure S2). Interestingly, the most highly
conserved domain in LuxN is centered at position P226 and con-
tains a PPAL motif that is 100% conserved among all known
LuxN homologs (Figure S2). Both proline residues of this motif
were identified as critical for LuxN signaling by our random mu-
tagenesis screen. Therefore, we hypothesize that the PPALmotif
is essential for LuxN signal transduction.
In a high-throughput chemical screen, fifteen small-molecule
antagonists were identified that specifically antagonize the
LuxN/AI-1 quorum-sensing circuit inV. harveyi. Theseare the first
antagonist molecules that target an AHL membrane-bound sen-
sor kinase. Interestingly, the antagonists identified by this screen
are not similar in structure to AI-1 (Figure 3A). Therefore, it is un-
likely that rational-design experiments would have predicted
these molecules as AHL antagonists. We wondered whether
our antagonists competed with AI-1 for binding to LuxN. To ex-
plore this, we performed an antagonist-suppressor screen, and
we identified LuxN* I209F, which is not antagonized by C450-
0730. Importantly, this mutation lies on the periplasmic side of
TM 6, in the center of our proposed AI-1 binding domain, consis-
tent with the possibility that C450-0730 competes for the AI-1
binding site (though the LuxN* mutation I209F does not affect
AI-1 signaling). We also obtained AI-1 dose-response curves in
the presence of different concentrations of C450-0730 for both
wild-type LuxN and LuxN F163A and obtained a good data col-
lapse indicative of competitive inhibition (Figures 3B and 3C).
Combined, these results strongly suggest that the C450-0730
antagonist is competing for the AI-1 binding pocket of LuxN.
Because the LuxN* I209F mutation only affects the antagonistic
ability of C450-0730 but does not interfere with AI-1 signaling,468 Cell 134, 461–473, August 8, 2008 ª2008 Elsevier Inc.we hypothesize that C450-0730 makes at least some contacts
with LuxN that are distinct from those made by AI-1.
Our discovery of LuxN mutations with both increased and de-
creased sensitivity to AI-1 suggests an analogy to chemotaxis
receptors in E. coli. Chemotaxis receptors are known to adjust
their sensitivity to ligand via reversible methylation of specific cy-
toplasmic residues (Goy et al., 1977; Kehry andDahlquist, 1982a,
1982b; Springer andKoshland, 1977; Stock andKoshland, 1978;
Terwilliger and Koshland, 1984). We wondered whether muta-
tions in LuxN could play the same role as methylation-demethy-
lation in chemotaxis—namely, could they shift the free-energy
bias between receptor kinase and phosphatase states? The re-
sulting model is shown schematically in Figures 5A and 5B. We
propose that each LuxN can exist in any of four states: kinase
(on) or phosphatase (off) with ligandbound or unbound. Receptor
activity is determined by the thermal equilibrium among these
states, characterized by the free-energy difference f between
the on and off states of LuxN (see the Experimental Procedures).
Within the model, the measured output, bioluminescence, is the
same unknown function of f for all strains, reflecting the fact that
bioluminescence depends only on receptor activity, which at
equilibrium depends only on f. Themodel predicts thatmutations
can cause EC50 to increase or decrease depending on the sign of
the shift inD3, the free-energy bias between kinase andphospha-
tase states. Indeed, the model is nicely supported by the data
collapse in Figure 3C, where the bioluminescence for the LuxN
F163Amutant collapses well with wild-type assuming only a shift
in D3. More generally, we have found that the bioluminescence
data for many of our LuxN mutants collapse well with the com-
bined wild-type and LuxN F163A data, allowing us to deduce
changed D3 values and in some cases also changed binding
affinities (Figures 6A and 6B). This analysis supports a close func-
tional analogy between LuxN and E. coli chemotaxis receptors
and suggests the general relevance of two-state, free-energy
models for bacterial sensor kinases.
The genetic screen used here enabled us to identify three clas-
ses of LuxN mutants. The first class of LuxN mutants identified
as LuxN* was unexpectedly revealed in the antagonist-suppres-
sor screen. Among these suppressor mutants, LuxN G271D,
S184N, and R245L, have increased sensitivity to AI-1 as indi-
cated by their reduced AI-1 EC50 values. These mutations are
not located in the proposed AI-1 binding domain. Rather, two
of these mutations, S184N and R245L are located within cyto-
plasmic loops 3 and 4, respectively, whereas G271D is located
at the periplasmic interface of TM8 (Figure 1B). We propose
that these mutations bias LuxN toward the phosphatase state,
such that lower AI-1 is needed to switch these mutant proteins
into the kinase (off) state than is required by wild-type LuxN.
Consistent with this idea, the AI-1 dose-response data for
LuxN R245L and LuxN G271D collapsed onto the data for
wild-type LuxN and LuxN F163A from Figure 3C when only the
D3 parameter was altered while the binding parameters were
kept constant at the wild-type values (Figure 6A). Specifically,
LuxN R245L and G271D required only an additional 0.5 be
added to D3 to collapse the data, whereas we had to decrease
D3 by 0.4 to collapse the data for the LuxN S184N mutant
(data not shown). Therefore, LuxN R245L and LuxN G271D be-
have as predicted if their mutations bias them toward the kinase
(off) state. Although we do not understand why LuxN S184N
does not follow this pattern, we suspect that the LuxN S184N
mutation must, in addition to affecting the free-energy bias,
also affect the rate of phosphotransfer or the rate of phosphatase
activity, two parameters not determined in either our experimen-
tal or theoretical analyses.
The second class of mutants includes LuxN T139I, V143A,
I153F, F155I, F163A, T206A, T214I, F220A, W224A, P226A,
and P227A, which bind and respond to AI-1 but are less sensitive
to AI-1 than is wild-type LuxN. Thus, this second class of
mutants requires increased AI-1 concentration to convert LuxN
from a kinase to a phosphatase.We favor the idea that thesemu-
tations diminish LuxN’s ability to respond to AI-1 by biasing LuxN
toward kinase mode, and indeed, the dose-response curves of
many of these mutants (e.g., LuxN T214I and LuxN W224A) col-
lapse well onto the combined wild-type and LuxN F163A data
collapse from Figure 3C with the wild-type binding-affinity pa-
rameters, KAI-1off and K
AI-1
on , while changing only the free-energy-
bias parameter D3 (Figure 6B). For these mutants, we note that
doing the reverse, i.e., changing the binding-affinity parameters
while maintaining the free-energy bias D3 at the wild-type level,
does not allow us to collapse the data. The second class also
contains mutants such as LuxN F155A and LuxN F162A that
have greatly increased AI-1 EC50 values compared to wild-type
LuxN, yet, when we adjust only D3, their dose-response curves
do not collapse onto the combined wild-type LuxN and LuxN
F163A data in Figure 3C. We could successfully collapse their
data by simultaneously adjusting D3 and increasing KAI-1off to
10 nM and 100 nM, respectively. This finding suggests that these
two LuxN mutations impair AI-1 binding in addition to shifting
the LuxN free-energy bias D3 toward the kinase (on) state.
Data from several other LuxN mutants (LuxN N133A, F151A,
I153A, F155L, L166A, F202Y, T214A, D219A, F220I, S221A,
P227L, and S232A) could not be collapsed even by simultaneous
adjustment of the D3 and KAI-1off values, suggesting that these
mutations have additional effects on receptor function.
The third class of mutants includes LuxN L166R, F202A,
S205P, P226T, and E233A. These LuxN mutant proteins do not
respond to AI-1 even at 500 mM. We interpret this to mean that
this particular class of LuxN mutants either cannot bind AI-1 or
is impaired in the ability to transduce the AI-1 signal to the kinase
domain of LuxN. These mutations all lie within our proposed AI-1
binding domain, suggesting that this region of LuxN is required
for both signal detection and signal transduction across the
bacterial membrane. As additional evidence supporting the
idea that this class of mutants is incapable of signaling, rather
than having AI-1 EC50 values shifted beyond our test range, we
combined one of these mutations (LuxN S205P) with one of
our heightened-sensitivity LuxN* mutations (LuxN R245L). The
double mutant remained dark at all AI-1 concentrations tested,
suggesting that the LuxN S205P mutation irreversibly cripples
signaling.
Our data-collapse method for deducing signaling parameters
did not require prior knowledge of the input-output function relat-
ing receptor activity to bioluminescence. The approach can
therefore be applied very generally, even to poorly characterized
pathways, as long as the final output is a function of receptor ac-
tivity. Indeed, one product of our analysis is the curve in Figure 3Cexpressing bioluminescence as a function of f  D3WT for LuxN.
One consideration in using data collapse is the possibility of
overfitting. For example, each of our AI-1 dose-response curves
Figure 5. LuxN Signal Transduction Can Be Described by a Two-
State Model
(A) Wild-type LuxN toggles between two conformations indicated by the open
and closed periplasmic domains. At low cell density, when the AI-1 concentra-
tion is negligible, LuxN is strongly biased toward its kinase state, represented
by the open periplasmic structure. At high cell density, in the presence of AI-1
(dark ovals), LuxN is biased toward the phosphatase state, represented by the
closed periplasmic structure.
(B) This two-state model is represented by a free-energy diagram that de-
scribes the two ligand-free forms of the protein as on (open periplasmic do-
main) or off (closed periplasmic domain). The free energies of these two states
are independent of ligand concentration and are represented by horizontal
black lines. The free energy of the on state is lower than the free energy of
the off state, producing the bias toward the kinase mode at low cell densities
(i.e., low autoinducer concentration). The free energy of LuxN in its phospha-
tase state and bound to ligand (offL) is represented by the descending solid
curve. The point at which the free energy of the offL state equals the free energy
of the on state (solid circle) corresponds to the EC50 value for AI-1. LuxN mu-
tants identified in the genetic screen that possess increased AI-1 EC50 values
are represented as on. Compared towild-type LuxN, they have lower on state
free energies and therefore exhibit larger AI-1 EC50 values. In contrast, the
three LuxN* mutants that exhibit a bias toward the phosphatase state are rep-
resented as on+. These mutants possess higher on state free energies than
wild-type LuxN and therefore have decreased AI-1 EC50 values. The EC50
values of the on and on+ mutants are represented by the open circles.Cell 134, 461–473, August 8, 2008 ª2008 Elsevier Inc. 469
can be described by a relatively simple function and requires at
most four parameters to describe (e.g., max, min, EC50, and Hill
coefficient). Therefore, a data collapse that allowed adjustment
of four parameters for each curve would occur trivially and would
not necessarily reflect the underlying biology. In our case, we
were able to obtain a good collapse with one or at most two pa-
rameter adjustments per curve. The collapse of the antagonist
data for LuxN F163A onto the wild-type curves in Figure 3C is
even more parsimonious because it requires adjustment of
only one parameter, D3 D3WT, to collapse all three curves.
One oversimplification in Figure 5B is that the EC50 value is in-
dicated to occur at the crossing of the free energies of the kinase
(on) state and the phosphatase (off) state with bound AI-1, i.e.,
where LuxN is active as a kinase approximately 50% of the
time. However, our measured EC50 values pertain to biolumines-
cence, which is an output at the end of the quorum-sensing path-
way. Because the relation between bioluminescence and LuxN
activity may be nonlinear, the EC50 value measured for biolumi-
nescence may be shifted from the point of half-maximal LuxN
kinase activity. Nevertheless, as long as this shift is not large,
we can estimate the wild-type bias D3 from the wild-type EC50
Figure 6. Data Collapse for LuxN*, LuxN Bias, and Combined
LuxN*-Bias Mutants
(A) Collapse of the dose-response data from LuxN* R245L andG271Dmutants
with the combined wild-type/LuxN F163A antagonist collapse from Figure 3C.
These LuxN* curves were collapsed by adjustment of only the bias D3D3WT
to +0.5.
(B) Collapse of dose-response curves from representative dark LuxN mutants
with the combined wild-type/LuxN F163A antagonist collapse from Figure 3C.
The LuxN W224A and LuxN T214I dose-response curves were collapsed by
adjustment of only the bias D3D3WT to 1.5 and 4.3, respectively. The
LuxN F155A and LuxN F162A dose-response curves were collapsed by
adjustment of the bias D3D3WT parameter and increase of the KAI-1off : for
LuxN F155A, D3D3WT = 1.0 and KAI-1off = 10 nM, and for LuxN F162A,
D3D3WT = 1.0 and KAI-1off = 100 nM.470 Cell 134, 461–473, August 8, 2008 ª2008 Elsevier Inc.value. Taking the observed EC50 value of 23 nM to be the con-
centration of AI-1 at which wild-type LuxN is active as a kinase
50% of the time implies that f = 0 in Equation 2 at this AI-1 con-
centration (Experimental Procedures). Using the values of KAI-1on=off
from our data collapse in Equation 2 then allows us to estimate
the wild-type bias as D3WT = 3.2 kBT. The corresponding prob-
ability for LuxN to be active as a kinase in the absence of AI-1 is
1/[1 + e3.2] = 96%. This strong preference for the kinase state in
the absence of AI-1 explains the large ratio between the ob-
servedwild-type EC50 value,20 nM, and the underlying binding
constant of 1 nM in the phosphatase (off) state. As shown
schematically in Figures 5A and 5B, for a large (negative) bias
D3, the ligand concentration required to switch from kinase to
phosphatase grows exponentially EC50  KAI-1off ejD3j. In this ex-
pression, the exponential factor ejD3j must be large to achieve
a high kinase probability in the absence of AI-1, so the EC50 value
KAI-1off (20 nM) must be much larger than the binding constant
(1 nM). Interestingly, this large ratio (20) of the EC50 value to
the underlying binding constant KAI-1off is opposite to that ob-
served for signaling by the chemotaxis network at low ligand
concentrations, where receptor clustering and approximately
equal kinase and phosphatase probabilities lead to a small ratio
(0.1) of the EC50 to the Koff of the chemotaxis receptors
(Keymer et al., 2006).
We suggest that the distinct design properties inherent in
the quorum-sensing and chemotaxis-signaling systems have
evolved to optimally solve very different biological problems. In
chemotaxis, bacterial cells must respond rapidly to small, differ-
ential changes in ligand concentration. Consistent with this,
chemotaxis receptors are poised to change signaling strength,
spending nearly half of their time in the on state. Moreover, the
chemotaxis receptors cluster, which promotes signal amplifica-
tion (Ames et al., 2002; Kim et al., 1999; Maddock and Shapiro,
1993; Sourjik and Berg, 2002) That is, when a particular receptor-
dimer binds a ligand, that event is transduced to nearby, un-
bound receptors, amplifying the cell’s response to small
changes in ligand concentration (Bray et al., 1998). Thus, the
chemotaxis system seems particularly well suited to facilitate
biased swimming in a chemical gradient. In contrast, the quo-
rum-sensing receptors (e.g., LuxN) have dramatically different
signaling properties. First, in the absence of ligand, the quo-
rum-sensing receptors are nearly always in the on state and
thus require a significant threshold ligand concentration to
switch off. Second, the quaternary arrangement of receptors
(at least in the case of LuxPQ) precludes clustering and thus
excludes chemotaxis-style signal amplification (Neiditch et al.,
2005, 2006). Therefore, the quorum-sensing apparatus appears
to be designed to respond slowly to the accumulation of ligand.
Critically, no alterations in gene expression occur after chemo-
taxis signaling—the output of the system is exclusively a change
in swimming direction. In contrast, a global alteration in gene ex-
pression is induced by quorum sensing. Thus, in chemotaxis, the
fate of the cell likely does not hinge on a single erroneous signal-
transduction event, whereas quorum sensing establishes a com-
mitted program, possibly making signaling mistakes fatal. We
suggest that this dramatic difference in the output of the two
systems selects for high-sensitivity differential signaling accom-
panied by amplification for chemotaxis, while selecting against
exactly those features in quorum-sensing signaling. The striking
difference between the resting states of the E. coli chemotaxis
system and the V. harveyi quorum-sensing system suggests
a broad utility in classifying other two-component regulatory sys-
tems into their proper kinase-bias regimes. Such categorization
would help define whether a particular two-component system
promotes a fast switch in behavior or a slow quasidevelopmental
process.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Media
All V. harveyi strains were derived from V. harveyiBB120 and grown aerobically
at 30C in either Luria-Marine (LM) broth or Autoinducer Bioassay (AB) broth.
Plasmids were maintained in E. coli strain XL10Gold (Stratagene) at 37C in LB
broth. Triparental conjugations were performed with the helper plasmid
pRK2013 as described (Ditta et al., 1980). When needed, chloramphenicol
(Cm) was added to a final concentration of 10 mg/ml and Isopropyl b-D-1-
thiogalactopyranoside (IPTG) to a final concentration of 500 mM. A list of
strains and plasmids used in this study is provided in the Supplemental Data
(Table S2).
DNA Manipulations
DNA manipulations were performed as described by Sambrook et al. (1989).
PCR reactions were performed with Herculase Enhanced DNA polymerase
(Stratagene). Restriction endonucleases, dNTPs, and T4 ligase were pur-
chased from New England Biolabs. Site-directed mutagenesis was performed
with the Quickchange II Site-Directed mutagenesis kit (Stratagene). QIAGEN
methods were used for plasmid preparations and PCR cleanups. Sequences
of primers are available by request.
luxN Mutant Library Construction
The luxN gene was amplified from wild-type V. harveyi BB120 by PCR and
cloned into vector pFED343 at the EcoRI andNcoI sites, making pLS1001.Mu-
tagenesis of the first 950 bases of luxN was performed with the error-prone
PCR kit Genemorph II EZclone (Stratagene). Resulting mutations were cloned
into vector pFED343. The luxN mutant library was conjugated into V. harveyi
DluxN DluxPQ strain JMH625. Exconjugates were selected on LM medium
agar supplemented with Cm. Approximately 30,000 mutants were screened
for reduced bioluminescence. Plasmids from dark mutants were isolated
and backcrossed into V. harveyi JMH625 to confirm phenotypes. The luxN
genes were sequenced and all mutations were engineered independently via
Quikchange site-directed mutagenesis (Stratagene). All single luxN mutant
constructs were conjugated into V. harveyi JMH625 for verification of the
phenotypes.
V. harveyi Strain Construction
For construction of the V. harveyi DluxMN, DluxPQ, DluxS mutant strain,
HLS253, the luxMN operon was deleted from strain FED119 (Neiditch et al.,
2006). Specifically, cosmid pBB1754, carrying luxMN, was modified by
deletion of DNA specifying the entire luxMN open reading frame. The resulting
plasmid, p1754::DluxMN, was introduced into V. harveyi FED119, and the
deletion was transferred to the chromosome for the generation of V. harveyi
strain HLS253.
Bioluminescence Assays
AI-1 dose-response curves were generated in V. harveyi strain HLS253
containing a vector with wild-type luxN or one of the luxN mutants. V. harveyi
strains were grown overnight in L-Marine (LM) medium containing Cm and
diluted 1:10,000 in autoinducer bioassay (AB) medium plus Cm and 0.5 mM
IPTG in triplicate in 96-well microtiter plates. AI-1 was added at either 100 mM
or 500 mM, and serial 4-fold dilutions were made to final AI-1 concentrations
of 24 pM and 119 pM, respectively. The cultures were allowed to grow to
stationary phase, at which time bioluminescence and optical density were
measured with a Perkin Elmer Envision plate reader.Quantitative Real-Time PCR Analysis
Wild-type and luxNmutant V. harveyi strains were grown in LMmedium in trip-
licate to an OD600 of 1.0, after which cell pellets were isolated and flash frozen
with liquid nitrogen. Pellets were stored at 80C prior to RNA isolation. RNA
was isolated and treated with DNase with the Ribo-Pure-Bacteria kit (Applied
Biosystems). RNA was quantified and 1 mg of RNA was converted to cDNA
with Superscript II reverse transcriptase (Invitrogen). Quantitative real-time
PCR analysis was performed with primers for qrr4 and hfq, where hfq served
as an internal control (Tu and Bassler, 2007).
Screen for LuxN Antagonists
The V. harveyi strains JMH624 and JMH610 were grown overnight in AB
medium and diluted 1:100 prior to the exogenous addition of either 20 nM
AI-1 or 20 nM AI-2, respectively. The diluted cultures were dispensed into
384 well microtiter plates, and the potential antagonist molecules were added
to each well. Each microtiter plate was duplicated so that variance could be
eliminated. The 35,000 molecule library was supplied by the Broad Institute
and the Initiative for Chemical Genetics (Cambridge, MA). Antagonist activity
was measured as a function of bioluminescence on a PerkinElmer Envision
plate reader.
LuxN Suppressor Screen
The luxN mutant library was conjugated into V. harveyi strain HLS253 and se-
lected on LM containing Cm. Colonies were inoculated into 96-well microtiter
plates containing LMbroth and Cm and grown at 30Cwith aeration to station-
ary phase. Glycerol was added to a final concentration of 20%, and the library
was stored at80C. Frozen stocks were partially thawed and used for the in-
oculation of duplicate 96-well microtiter plates containing ABmediumwith Cm
and IPTG. To one plate, 100 nM AI-1 and 800 nM antagonist C450-0730 was
added, whereas the duplicate control plate had neither AI-1 nor C450-0730
added. The plates were incubated at 30C with aeration until the cultures
reached stationary phase, at which time bioluminescence was measured
and the two plates were compared. Strains from wells that produced light in
the AI-1/C450-0730 plates but did not produce light in the control plates (no
AI-1/no C450-0730) were analyzed further. The luxNmutant plasmids were se-
quenced so that the mutations responsible for the observed phenotypes could
be determined, and the mutations were reengineered via Quikchange site-
directed mutagenesis (Stratagene).
LuxN Free Energies, Competitive Binding, and Data Collapse
In equilibrium, the probability for a LuxN to be active as a kinase is determined
by the free-energy difference, f = fon – foff, between its kinase (on) and phospha-
tase (off) states according to
pon =
1
1+ ef
: (1)
(Wemeasure all energies in units of the thermal energy kBT.) Assuming com-
petitive binding of AI-1 and C450-0730, one obtains
f =D3+ log
0
@1+
½AI1
KAI1
off
1+ ½AI1
KAI1on
1
A+ log
0
@1+
½C4500730
KC4500730
off
1+ ½C4500730
KC4500730on
1
A; (2)
where K
AI-1=C450-0730
on=off is the dissociation constant for the given state and ligand
and the ‘‘bias’’ D3 is the value of f at zero ligand concentration (Keymer et al.,
2006).
To test for competitive binding of C450-0730 to LuxN, we assume that bio-
luminescence is some (unknown) function of the fraction of LuxN proteins that
are active as kinases, i.e., bioluminescence is a function of f. We therefore plot
bioluminescence as a function of f – D3WT, as given in Equation 2, and search
for the values of K
AI-1=C450-0730
on=off that collapse all of our data onto a single curve.
The results are shown in Figure 3C.
To quantitatively test whether LuxNmutations that shift AI-1 EC50 values can
be attributed to changes in the bias D3 and/or the AI-1 binding affinities, we
attempted to collapse the AI-1 dose-response curves for each mutant onto
the wild-type curve (Figure 6B) using D3mutant  D3WT and in some cases KAI-1offCell 134, 461–473, August 8, 2008 ª2008 Elsevier Inc. 471
as fitting parameters. The collapse was satisfactory for many but not all
cases, as discussed in the text.
SUPPLEMENTAL DATA
Supplemental Data include two figures, two tables, and Supplemental Refer-
ences and can be found with this article online at http://www.cell.com/cgi/
content/full/134/3/461/DC1/.
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